Frontiers | Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential | ACS Infectious Diseases
Migration and Transformation Characteristics of Niclosamide in a Soil–Plant System | ACS Omega
Dehydration of Niclosamide Monohydrate Polymorphs: Different Mechanistic Pathways to the Same Product | Crystal Growth & Design
Niclosamide Exposure at Environmentally Relevant Concentrations Efficaciously Inhibited the Growth and Disturbed the Liver-Gut Axis of Adult Male Zebrafish | Environmental Science & Technology
Frontiers | The magic bullet: Niclosamide
Niclosamide - brand name list from Drugs.com
Frontiers | Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
News – Center for Drug Repurposing
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway | PLOS ONE
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis - ScienceDirect
Frontiers | The magic bullet: Niclosamide
Pharmaceutical Cocrystals of Niclosamide | Crystal Growth & Design
Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents | ACS Medicinal Chemistry Letters
Using Salt Cocrystals to Improve the Solubility of Niclosamide | Crystal Growth & Design
Frontiers | Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
StudyPages - Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
Frontiers | The magic bullet: Niclosamide
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection - ScienceDirect
Niclosamide, STAT3 inhibitor (CAS 50-65-7) (ab120868) | Abcam
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment | bioRxiv
JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo | ACS Infectious Diseases
CAS Number 50-65-7 | Niclosamide
Frontiers | Niclosamide Blocks Rice Leaf Blight by Inhibiting Biofilm Formation of Xanthomonas oryzae
